- Transcatheter Aortic Valve Implantation (TAVI/TAVR)
- Valvular heart disease
- Live Cases
- Aortic Stenosis (AS)
TAVR with Lotus Edge
CSI is the leading conference on catheter therapy of congenital, structural and valvar heart disease and heart failure interventions worldwide. Lead by experts in the field, CSI supports and...
CSI is the leading conference on catheter therapy of congenital, structural and valvar heart disease and heart failure interventions worldwide. Lead by experts in the field, CSI supports and promotes global and multidisciplinary collaboration by providing educational congresses, workshops and online learning opportunities like live cases and webinars. It is our goal to stay at the forefront of technology, innovation and medical device development and we achieve this through close collaboration with our worldwide network of physicians, healthcare providers and industry professionals.
csi-congress.org
Speakers
Lars Sondergaard
Speaker
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark.... Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
